BioTelemetry Stock News

The healthcare industry is now starting to shift its focus away from the coronavirus pandemic to work on its core activities.

September was another lackluster month for the stock market, with the S&P 500 dropping by over 9%.

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the

Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday. Agrify Corporation (NASDAQ: AGFY) climbed 88% to close at $ 0.9540 on Wednesday after cl

SANTA CLARA, Calif.

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. Atlis Motor Vehicles, Inc. (NASDAQ: AMV) climbed 95.5% to close at $24.49. InVivo Therapeutics H

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of Radia

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Thursday. Following the market opening Thursday, the Dow traded down 0.82% to 30,026.56 while the NASDAQ fell

Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is seeing gains on Thursday as investors react to news of it expanding its product portfolio pipeline. That expansion has t

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target. BigBea

Gainers Windtree Therapeutics, Inc (NASDAQ: WINT) rose 50.7% to $0.4827 in pre-market trading after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The tria

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at Upcoming Investor Conferences

Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA f